Comparison of histidine-tryptophan ketoglutarate solution and University of Wisconsin solution in prolonged cold preservation of kidney allografts

Transplantation

Volumn 81, Issue 3, 2006, Pages 480-482

  Agarwal, Avinash ^a   Murdoch, Philip ^b   Fridell, Jonathan A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Indiana Organ Procurement Organization   (United States)

Author keywords

Histidine Tryptophan Ketogluatarate (HTK) solution; Kidney transplantation; Organ preservation solution; Organ procurement; University of Wisconsin (UW) solution

Indexed keywords

HISTIDINE TRYPTOPHAN KETOGLUTARATE; PRESERVATION SOLUTION; UNCLASSIFIED DRUG; UNIVERSITY OF WISCONSIN SOLUTION;

ADULT; ARTICLE; COHORT ANALYSIS; CRYOPRESERVATION; FEMALE; GRAFT DYSFUNCTION; GRAFT SURVIVAL; HUMAN; INTERMETHOD COMPARISON; KIDNEY ALLOGRAFT; KIDNEY GRAFT; KIDNEY PRESERVATION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL;

ADENOSINE; ADULT; ALLOPURINOL; COLD ISCHEMIA; FEMALE; GLUCOSE; GLUTATHIONE; GRAFT SURVIVAL; HUMANS; INSULIN; KIDNEY; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MANNITOL; MIDDLE AGED; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; POTASSIUM CHLORIDE; PROCAINE; RAFFINOSE;

EID: 32844466515     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000196724.89757.79     Document Type: Article

References (11)

1. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg 1980; 28(5): 295-302.
2. de Boer J, Smits JM, DeMeester J, et al. A randomized multicenter study on kidney preservation comparing HTK with UW. Transplant Proc 1999; 31(5): 2065-2066.
3. Agarwal A, Goggins WC, Pescovitz MD, et al. Comparison or histidine-tryptophan ketoglutarate and University of Wisconsin solutions as primary preservation in renal allografts undergoing pulsatile perfusion. Transplant Proc 2005; 37(5): 2016-2019.
4. Fridell JA, Agarwal A, Milgrom ML, et al. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution for organ preservation in clinical pancreas transplantation. Transplantation 2004; 77(8): 1304-1306.
5. Potdar S, Malek S, Eghtesad B, et al. Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplant 2004; 18(6): 661-665.
6. Mangus R, Tector A, Agarwal A, et al. A Comparison Of Histidine-Tryptophan-Ketoglutarate Solution (HTK) and University of Wisconsin Solution (UW) In Adult Liver Transplantation. Liver Transpl 2005; 37(5): 2016-2019.
7. de Boer J, De Meester J, Smits JM, et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int 1999; 12(6): 447-453.
8. Roels L, Coosemans W, Donck J, et al. Inferior outcome of cadaveric kidneys preserved for more than 24 hr in histidine-tryptophan-ketoglutarate solution. Leuven Collaborative Group for Transplantation. Transplantation 1998; 66(12): 1660-1664.
9. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333(6): 333-336.
10. Light JA, Gage F, Kowalski AE, et al. Immediate function and cost comparison between static and pulsatile preservation in kidney recipients. Clin Transplant 1996; 10(3): 233-236.
11. Groenewoud AF, Thorogood J. Current status of the Eurotransplant randomized multicenter study comparing kidney graft preservation with histidine-tryptophan-ketogluterate, University of Wisconsin, and Euro-Collins solutions. The HTK Study Group. Transplant Proc 1993; 25(1 Pt 2): 1582-1585.